Terms: = Lung cancer AND USP8, FLJ34456, 9101, ENSG00000138592, KIAA0055, P40818, MGC129718, UBPY, HumORF8 AND Treatment
7 results:
1. Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the treatment of ALK-Positive Non-Small Cell lung cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing.
Abuhejail RM; Alzoman NZ; Darwish IA
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894533
[TBL] [Abstract] [Full Text] [Related]
2. Targeting usp8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT.
Tang J; Long G; Hu K; Xiao D; Liu S; Xiao L; Zhou L; Tao Y
Adv Sci (Weinh); 2023 Nov; 10(33):e2302953. PubMed ID: 37867237
[TBL] [Abstract] [Full Text] [Related]
3. The ubiquitin-specific protease 8 antagonizes melatonin-induced endocytic degradation of MT
Sun Q; Zhang J; Li X; Yang G; Cheng S; Guo D; Zhang Q; Sun F; Zhao F; Yang D; Wang S; Wang T; Liu S; Zou L; Zhang Y; Liu H
J Adv Res; 2022 Nov; 41():1-12. PubMed ID: 36328739
[TBL] [Abstract] [Full Text] [Related]
4. Feasibility of postoperative adjuvant chemotherapy using carboplatin plus S-1 in completely resected non-small cell lung cancer patients.
Inoue M; Kusumoto H; Shiono H; Shintani Y; Ose N; Sakamaki Y; Okami J; Higashiyama M; Takeuchi Y
J Chemother; 2019 Oct; 31(6):343-348. PubMed ID: 31409216
[TBL] [Abstract] [Full Text] [Related]
5. usp8 is a novel target for overcoming gefitinib resistance in lung cancer.
Byun S; Lee SY; Lee J; Jeong CH; Farrand L; Lim S; Reddy K; Kim JY; Lee MH; Lee HJ; Bode AM; Won Lee K; Dong Z
Clin Cancer Res; 2013 Jul; 19(14):3894-904. PubMed ID: 23748694
[TBL] [Abstract] [Full Text] [Related]
6. A case-matched study of stereotactic radiosurgery for patients with multiple brain metastases: comparing treatment results for 1-4 vs ≥ 5 tumors: clinical article.
Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Barfod BE; Kasuya H; Urakawa Y
J Neurosurg; 2013 Jun; 118(6):1258-68. PubMed ID: 23600938
[TBL] [Abstract] [Full Text] [Related]
7. First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study.
Gatzemeier U; von Pawel J; Vynnychenko I; Zatloukal P; de Marinis F; Eberhardt WE; Paz-Ares L; Schumacher KM; Goddemeier T; O'Byrne KJ; Pirker R
Lancet Oncol; 2011 Jan; 12(1):30-7. PubMed ID: 21169060
[TBL] [Abstract] [Full Text] [Related]
